Nomogram model for predicting papillary thyroid carcinoma based on clinical-ultrasound characteristics and inflammatory biomarkers: a multicenter study
Frontiers in Oncology · 13.04.2026 · 16
DOI: 10.3389/fonc.2026.1752376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 13.04.2026. Verfasst von Caihong Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Medical Imaging, Guizhou Medical University, Guiyang, Guizhou, China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
The predictive significance of lymphocyte-related inflammatory biomarkers for papillary thyroid carcinoma (PTC) remains unclear. This study aims to provide a new tool for differentiating PTC from benign thyroid nodule (BTN) by constructing a nomogram model.
Methods
Institution A (n=733) was randomly divided into a training cohort (n=513) and an internal validation cohort (n=220) at a 7:3 ratio. Institution B (n=164) served as external validation cohort 1, while Institutions C and D (n=143) were combined as external validation cohort 2. In the training cohort, a nomogram model was constructed by stepwise selection of features through univariate and multivariate logistic regression. The model’s discrimination, calibration, and clinical applicability were assessed using the area under the receiver operating characteristic curve (AUC), decision curve analysis (DCA), and clinical impact curve (CIC).
Results
The final nomogram integrated the inflammatory biomarker NLR with patient age and Ultrasound(US) features. This model demonstrated excellent predictive performance across the training cohort (AUC 0.841, 95%CI: 0.807-0.872), internal validation cohort (AUC 0.828, 95%CI: 0.772-0.876), external validation cohort 1 (AUC 0.756, 95%CI: 0.683-0.820), and external validation cohort 2 (AUC 0.833, 95%CI: 0.762-0.890). DCA and CIC evaluations further confirmed the model’s good calibration and significant net clinical benefit.Additionally,1000 bootstrap resamplings in the entire dataset demonstrated robust diagnostic performance(AUC 0.826, 95%CI: 0.798-0.852).The nomogram maintained robust generalizability and clinical practical value across different centers, populations, and examination equipment.
Conclusion
The nomogram model we developed has good diagnostic performance and provides added value for the individualized diagnosis and treatment of PTC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academy of Medical Imaging, Guizhou Medical University, Guiyang, Guizhou, China.
- The Second People's Hospital of Guizhou Province, Guiyang, Guizhou, China.
- Department of Ultrasound Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, C., Yang, Y., Hua, Y., Qin, D., Cai, Y., Feng, R., & Wen, J. (2026). Nomogram model for predicting papillary thyroid carcinoma based on clinical-ultrasound characteristics and inflammatory biomarkers: a multicenter study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1752376
Vancouver
Wang C, Yang Y, Hua Y, Qin D, Cai Y, Feng R, et al. Nomogram model for predicting papillary thyroid carcinoma based on clinical-ultrasound characteristics and inflammatory biomarkers: a multicenter study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1752376
BibTeX
@article{Wang2026,
author = {Wang, Caihong and Yang, Ying and Hua, Yuyu and Qin, Dan and Cai, Yan and Feng, Ruheng and Wen, Jing},
title = {Nomogram model for predicting papillary thyroid carcinoma based on clinical-ultrasound characteristics and inflammatory biomarkers: a multicenter study},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1752376}
}
EUVIMED